The Hirshberg Foundation is excited to have Dr. Stephen Pandol joining us at the 14th Annual Symposium on Pancreatic Cancer to discuss how medical professionals from around the world are collaborating and making a difference in pancreatic cancer.
Stephen Pandol, MD, is board-certified in internal medicine, and gastroenterology. He leads a multidisciplinary team comprised of molecular and cell biologists, computational chemists, clinical scientists, physicians and population scientists, with the common goal of developing enhanced treatments and improved outcomes for patients with pancreatic cancer, pancreatitis and diabetes.
Dr. Pandol’s research focuses on determining the changes in intracellular signaling and organelle disorders that occur when pancreatitis develops; the mechanisms of cells involved in promoting the growth and metastasis of pancreatic cancer, and how nutrients in the intestine activate gut endocrine cells in diabetes to regulate glucose metabolism and food intake. He has published more than 250 papers, including peer-reviewed articles, reviews and book chapters, and more than 180 abstracts. He is on the editorial boards of American Journal of Physiology Gastrointestinal and Liver Physiology and Gastroenterology and is a Chief Editor on Frontiers in Gastrointestinal Sciences, and a Consulting Editor on Journal of Clinical Investigation.
Dr. Pandol is currently Co-Lead of the Consortium to Study Chronic Pancreatitis, Diabetes, and Pancreatic Cancer and a Counselor for the American Gastroenterology Association. He received the Lifetime Achievement Award from the American Pancreatic Association in 2015.
Dr. Pandol will speak on How Global Collaboration is Making a Difference at the 14th Annual Symposium on Pancreatic Cancer held at UCLA.
